Current Clinical Trials

Current Clinical Trials

Currently we are conducting the following Clinical Trial(s):

 

    1. Narcolepsy Clinical Trial: Patients ages 18-65, with Narcolepsy. This study is looking at the effect of a new medicine on sleepiness in patients with Narcolepsy who have access to their previous test results confirming Narcolepsy. The study lasts about 5 weeks, with three sleep testing stays (overnight and the next day) with us. Patients may get active medicine or placebo. We pay $1700 for the subject’s time and expenses upon completing the study.
    2. Idiopathic Hypersomnia Open Label Clinical Trial with Double Blind Withdrawal: Patients age 18 or older, with Idiopathic Hypersomnia (IH). This study looks at the effect of a new medicine on sleepiness in patients with IH. This starts as an open-label study in which everyone gets medicine. Patients may stay on previous medicines for IH if they are still excessively sleepy on them.  who have access to their previous test results confirming Narcolepsy. The study lasts about 14 weeks, with 5 office visits and several phone calls. If patients do well on this medicine, there is a 4 week period during which they may get medicine or placebo. Patients may get active medicine of placebo. We pay $950 for the subject’s time and expenses upon completing the study. At the end of the study, patients may join an open label extension study during which they get the medicine for sure for several months.

Clinical trials come and go, and they fill up fast.

How do I participate?

Call our office at 586-254-0707, or fill out a request for us to contact you.

What is the Best Pillow?

What is the Best Pillow? Patients often ask us, “What is the best pillow?” Patients also ask whether there is a pillow to use with CPAP, or a pillow that treats snoring and sleep apnea. According to Consumer Reports, the best pillow is Coop Home Goods Premium Adjustable Loft, followed closely by Sleep Number ComfortFit…

Amphetamines should not be stimulants of first choice

Amphetamines should not be stimulants of first choice Amphetamines in DEA Schedule 2 (AdderallR, DexedrineR, VyvanseR) are the most commonly prescribed stimulants in the USA. These amphetamines should not be the stimulants of first choice. However, amphetamine use increased 2.5 fold from 2006 to 2016. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261411/) Stimulant medicines (amphetamines, methylphenidate, modafinil, armodafinil, solriamfetol) are generally…

Obstructive Sleep Apnea Almost Doubles the Risk of Sudden Death

Obstructive Sleep Apnea Almost Doubles the Risk of Sudden Death A large analysis of 22 studies with 42099 subjects showed that obstructive sleep apnea (OSA) almost doubles the risk of sudden death. The risk of sudden death of any cause was increased by 74%, and the risk of cardiovascular deaths by 95%. The authors looked…

Schedule An Appointment Today

44344 Dequindre Rd Suite 360
Sterling Heights, MI 48314
click here for directions